Zheng-Ying Sung

Zheng-Ying Sung

Auto-generated profile, based on publicly available information

Zheng-Ying Sung

Department of Biomedical Engineering, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2024 in Materials Advances
Verified
Journal Article
Open access
PDF file
YWYu-Chi Wang
Yu-Chi Wang
FTFu-I Tung
Fu-I Tung
ZSZheng-Ying Sung
Zheng-Ying Sung
MCMEI-HSIU CHEN
MEI-HSIU CHEN
MCMing-Hong Chen
Ming-Hong Chen
TLTse-Ying LIU
Tse-Ying LIU
Metastasis is a major issue in cancer therapy, resulting in poor prognosis and death. However, there is currently no widely established prophylactic strategy for early metastasis in the clinical setting. Although water-soluble EuCl3·6H2O has the potential to exhibit a metastasis-inhibiting effect similar to migrastatics and matrix metalloproteinase inhibitors (MMPIs), intravenous administration of europium (Eu)-containing compound solution may not efficiently accumulate Eu ions in tumors and could be rapidly cleared from the body. In this study, we developed Eu ion-doped superparamagnetic iron oxides incorporated into bovine serum albumin hybrid nano-complexes (Eu:SPIO@BSA nano-complexes) to enhance tumor accumulation and prevent metastatic osteosarcoma via intravenous administration. In vitro studies showed that Eu:SPIO@BSA nano-complexes had a migration-inhibiting effect and affected pseudopodia formation in K7M2 cells. In vivo studies showed that distant lung metastasis was inhibited by the magnetism-enhanced targeted delivery of Eu:SPIO@BSA nano-complexes. Taken together, our results provide evidences that the Eu:SPIO@BSA nano-complex, with precise delivery, higher hemocompatibility and low liver toxicity, is a potential candidate for improving the therapeutic efficacy of metastasis prevention in osteosarcoma.